Skip to main content

GENERAL COMMENTARY article

Front. Genet., 26 March 2014
Sec. Statistical Genetics and Methodology
Volume 5 - 2014 | https://doi.org/10.3389/fgene.2014.00061
This article is part of the Research Topic Assessing the Effects of Multiple Markers in Genetic Association Studies View all 19 articles

Corrigendum: Exploring the potential benefits of stratified false discovery rates for region-based testing of association with rare genetic variation

This article is a commentary on:

  1. Exploring the potential benefits of false discovery rates for region-based testing of association with rare genetic variation

    1. Read original article
\r\nCelia M. T. Greenwood*Celia M. T. Greenwood*
  • Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada

An erratum on
Exploring the potential benefits of stratified false discovery rates for region-based testing of association with rare genetic variation

by Xu, C., Ciampi, A., and Greenwood, C. M. T. (2014). Front. Genet. 5:11. doi: 10.3389/fgene.2014.00011

Regrettably, the Acknowledgments were omitted from the submitted manuscript and are therefore included here in this Corrigendum

Acknowledgments

The authors were supported by CIHR operating grant MOP-115110 to Celia M. T. Greenwood and Antonio Ciampi, and also by MITACS, the Mathematics of Information Technology and Complex Systems, part of the Canadian Networks of Centres of Excellence program. This study makes use of data generated by the UK10K Consortium, derived from samples from UK10K_COHORTS_TWINSUK (The TwinsUK Cohort) and UK10K_COHORT_ALSPAC (the Avon Longitudinal Study of Parents and Children). A full list of the investigators who contributed to the generation of the data is available from www.UK10K.org. Funding for UK10K was provided by the Wellcome Trust under award WT091310.

Keywords: Acknowledgments, false discovery rates, rare genetic variation, UK10K, region-based tests

Citation: Greenwood CMT (2014) Corrigendum: Exploring the potential benefits of stratified false discovery rates for region-based testing of association with rare genetic variation. Front. Genet. 5:61. doi: 10.3389/fgene.2014.00061

Received: 07 March 2014; Accepted: 11 March 2014;
Published online: 26 March 2014.

Edited and reviewed by: Joanna Biernacka, Mayo Clinic, USA

Copyright © 2014 Greenwood. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence:Y2VsaWEuZ3JlZW53b29kQG1jZ2lsbC5jYQ==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.